ArticleHuman vaccines & immunotherapeutics2025

An active post-marketing surveillance study to evaluate the safety and immunogenicity of Zyvac TCV in healthy participants.

Sanjay Vasant Mankar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.